Feline leukemia virus (FeLV) is a horizontally transmissible C-type retrovirus identified as a causative agent of a spectrum of lymphoid malignancies that affect domestic cats and that are collectively referred to as leukemia-lymphosarcoma complex. FeLV is a representative of the slowly transforming retroviruses, since the development of FeLVmediated leukemia-lymphosarcoma complex in cats occurs after a relatively long latency period of several months to years (23, 29) . FeLV contains no genetic information to which its oncogenic potential can be directly attributed, and the molecular mechanism by which it induces malignancy is unknown. FeLV is unusually promiscuous in its genetic interactions with host proto-oncogenes, however, and natural variants of FeLV have been described which contain the oncogenes fes, fms, fgr, abl, sis, kit, and myc (4-7, 15, 19, 35, 37, 38, 51) . These observations suggest that the transduction of oncogenes by FeLV may contribute significantly to neoplastic induction by this retrovirus.
Among the variants of FeLV which contain oncogenes, all are derived from feline fibrosarcomas except those which contain myc (4-7, 15, 19, 37, 51) . The myc-containing variants have been isolated from naturally occurring T-cell lymphosarcomas in domestic cats (31, 35, 38) . These variants are significant, then, in two respects. First, their isolation from lymphoid malignancies provides evidence that oncogene-containing derivatives of classical leukemogenic retroviruses play a role in mammals in the induction of hematopoietic neoplasms. The Abelson murine leukemia virus is associated with the induction of such neoplasms following it. parenteral introduction in mice (1) . Second, they represent the only naturally occurring mammalian retroviruses which contain myc as an oncogene. The tumorigenic potential of the myc-containing FeLV variants remains uncharacterized. These variants may encode significant oncogenic activity, since the avian retroviruses which contain myc as an oncogene induce a remarkable spectrum * Corresponding author.
of tumors in vivo, including myelocytomas, carcinomas, and sarcomas. The broad tumorigenic potential is reflected in the capacity of these viruses to transform hematopoietic, epithelial, and fibroblastic cells in vitro (8, 16, (20) (21) (22) 33) . Similarly, recombinant murine retroviruses which contain avian v-myc oncogenes have been shown to transform established murine fibroblast lines to anchorage-independent growth, to transform primary mouse fibroblasts morphologically and to anchorage-independent growth, and to transform primary and early-passage murine macrophages (12, 49) .
A myc-containing variant of FeLV, termed myc-FeLV, was originally isolated as proviral DNA, 5.5 kilobase pairs (kbp) in length, from a naturally occurring feline thymic lymphosarcoma (31) . The myc-FeLV provirus contains a spliced version of the c-myc gene, 1.34 kbp in length, which has replaced the pol gene and part of the gag and env genes of the FeLV parent from which it was derived (11) . Nucleotide sequence analysis demonstrates that the coding sequences shared by feline v-myc and c-myc are identical and share 90% identity with murine and human c-myc genes (11, 45) . Feline v-myc lacks most of the unusually long, untranslated exon 1 of c-myc, an observation which may be significant in that the transforming function of avian v-myc genes and of some activated c-myc genes is correlated with the absence of an equivalent c-myc exon 1 (2, 3, 11, 24, 40, 42, 44, 45) . The reading frame of feline v-myc is continuous with that of the FeLV gag gene, indicating that the v-myc gene product is expressed as a gag-myc fusion protein (11) . Reported here are studies of the transforming potential of myc-FeLV in primary and early-passage feline cells in vitro.
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calf serum (GIBCO Laboratories). The FEA cell line, a continuous line of feline fibroblasts, both uninfected and infected with biologically cloned FeLV-A/Glasgow-1 (27) , were the gift of Jennifer Rojko, The Ohio State University. Molecularly cloned, infectious proviral DNA of FeLV-B/Gardner-Arnstein (36) was the gift of J. W. Casey. The EcoRI restriction fragment of the clone, containing fulllength proviral DNA and human DNA flanking sequences, was subcloned into plasmid vector pUC9 by standard procedures (34) . Proviral DNA of myc-FeLV, molecularly cloned as an 8-kbp BamHI fragment containing full-length proviral DNA and feline DNA flanking sequences, has been described previously (31) .
DNA-mediated transfection and assay for productive infection. Supercoiled recombinant plasmid vector containing proviral DNA (10 ,ug) was introduced with D-17 DNA (20 ,ug) as a calcium phosphate precipitate (48) into 107 D-17 cells. For cotransfections, the plasmid containing myc-FeLV proviral DNA was used in 20-fold mass excess over the plasmid containing the FeLV provirus (10 ,ug to 0.5 ,ug). After 4 h, the cells were washed and exposed briefly to 15% glycerol as described previously (48) . To assay for productive viral infection in D-17 cells, reverse transcriptase activity in the culture supernatants was measured essentially as described previously (30) .
Preparation and infection of primary feline cell cultures. Polybrene (1 ,ug/ml) was included in all inocula and in the mock infection (47) . An equal number of focus-forming units of FeLV-A/Glasgow-1 (27) Total cellular RNA was prepared by using guanidine isothiocyanate (13) , and poly(A)+ RNA was isolated by using oligo(dT)-cellulose affinity chromatography (32 (50) was used for this purpose. RESULTS Rescue of horizontally transmissible myc-FeLV(FeLV). Proviral DNA of myc-FeLV, molecularly cloned from a naturally occurring thymic lymphosarcoma (31), was assumed to be replication defective, since portions of the genes required for its structure and replication have been replaced by feline v-myc (Fig. 1A) . Therefore, we attempted to rescue horizontally transmissible myc-FeLV particles in the presence of replication-competent FeLV as helper. Molecularly cloned proviral DNAs of myc-FeLV and of FeLV-B/Gardner-Arnstein were introduced as a calcium phosphate precipitate into D-17 cells, a continuous canine cell line derived from an osteogenic sarcoma (41) . Proviral DNAs were introduced in a mass ratio of 20 myc-FeLV to 1 FeLV. As controls, D-17 cells were similarly transfected with FeLV proviral DNA alone or were mock transfected. The recipients of transfected DNA were not isolated from the population, but were allowed to remain in culture with other cells which did not take up DNA. Virions generated by the original recipients of transfected DNA were thus allowed to spread throughout the culture by horizontal infection. These cultures are referred to hereafter as infected D-17 cells.
An assay for the presence of reverse transcriptase activity in the supernatants of cultures into which proviral DNA was introduced was positive initially at 8 weeks after transfection and remained positive thereafter. Such activity has never been detected in the supernatants of mock-transfected cultures. Southern blot analysis of DNA prepared from these cells demonstrated the presence of integrated proviral DNAs of FeLV and myc-FeLV (data not shown). The presence of integrated myc-FeLV proviral DNA in a sufficient number of infected D-17 cells to allow its detection by Southern blot analysis indicates that the myc-FeLV proviral DNA introduced originally by transfection is transcriptionally active and contains the signals required for its encapsidation and horizontal spread.
To document this, viral RNA was prepared as described elsewhere (Levy and Lobelle-Rich, submitted) from the Blots were hybridized with radiolabeled probes representing either the U3 region of the FeLV LTR (31) or the 3' exon of feline c-myc (3'fcm) (31 (Fig. 1B, lanes A and B) . RNA prepared from the culture supernatant of cells infected with FeLV alone contained nothing homologous to a probe representing exon 3 of the feline c-myc gene (3'fcm) (Fig. 1B,  lane C) ; however, the 5.0-kb transcript of myc-FeLV was clearly evident when the 3'fcm probe was used to examine RNA prepared from the supernatants of cultures into which both FeLV and myc-FeLV were introduced (Fig. 1B, lane  D) . Thus these supernatants contain a complex, referred to by convention as myc-FeLV(FeLV), in which the genomes of both FeLV and myc-FeLV are encapsidated in horizontally infectious particles.
Northern blot analysis of viral RNA indicated that the abundance of particles containing the 8.2-kb genome of helper FeLV was much greater than the abundance of those containing myc-FeLV, particularly since the amount of viral RNA required to visualize the 8.2-kb species was much less than that required to visualize the 5.0-kb species (Fig. 1B) . Dot blot analyses of the same viral RNA preparations were performed to quantitate the proportion of myc-FeLV(FeLV) occupied by particles encapsidating the myc-FeLV genome. For this purpose, viral RNA was spotted directly onto nitrocellulose and was hybridized either to the U3 or to the 3'fcm probe, both of which had been radiolabeled to the same specific activity. The dots were then removed and dried, and the amount of bound radioactivity was determined by liquid scintillation counting. After correction for the relative lengths of the hybridizing region (370 nucleotides for the U3 probe [17] and 575 nucleotides for the 3'fcm probe [11] ) and for the relative amounts of RNA in each dot, the data indicated that particles containing the myc-FeLV genome represented only 2% of the total population (data not shown (Fig. 2A, lanes g to k) . An identical analysis with a probe representing the 3' exon of the feline c-myc gene (31) (Fig. 2B) (31) . Digestion with KpnI yielded two fragments homologous to the probe from each integrated FeLV provirus: (i) an internal fragment, identical in length among the proviruses, and (ii) the 5' host-virus junction fragment, whose length depends on the position of the KpnI recognition site in host DNA flanking each provirus (Fig. 1A) . Thus the junction fragments in a mass infection are not apparent unless the culture is clonal. This analysis demonstrated a random pattern of proviral integration in splenocytes infected with FeLV alone (Fig. 2C, lane b) and in thymocytes infected with myc-FeLV(FeLV) (Fig. 2C,  lane f) , since discrete host-virus junction fragments cannot be discerned. In contrast, the appearance of such fragments in the DNA of splenocytes infected with myc-FeLV(FeLV) (Fig. 2C, lane c) indicates that a clonal subpopulation predominated in this culture. The increased lifespan and distinctive morphology observed in this culture may reflect the phenotype of the clonally expanded subpopulation.
A clonal pattern of proviral integration was similarly observed in thymocytes infected with FeLV alone (Fig. 2C , lane e). These cells persisted in culture for 34 weeks, compared with the 12-week lifespan of identical cells which were mock infected or infected with myc-FeLV(FeLV) ( Table 1 Kitten fibroblasts demonstrated no evidence of transformation in response to infection with myc-FeLV (Table 1) . Mock-infected, FeLV-infected, and myc-FeLV(FeLV)-infected kitten fibroblasts continued to grow in liquid medium as monolayers of strongly adherent cells with typically fibroblastic morphology for 12 weeks, after which their growth declined ( Table 1 ). The cells failed to form colonies in semisolid medium and failed to proliferate when the serum concentration in liquid medium was decreased from 10 to 0.5% (Table 1) . That these cells were indeed infected is demonstrated by the presence of reverse transcriptase activity in the culture supernatant and by Northern blot analysis of virion RNA. Virion RNA samples prepared from the supernatants of kitten fibroblasts exposed to either FeLV or myc-FeLV(FeLV) were shown to contain the 8.2-kb genome of FeLV, but did not contain the 5.0-kb genome of mycFeLV ( Fig. 2A, lanes d to f) . Identical analysis with a probe representing the 3' exon of the feline c-myc gene (31) also failed to demonstrate the myc-FeLV genome (data not shown). As was the case with leukocytes exposed to mycFeLV(FeLV), the myc-FeLV genome is apparently lost in the absence of the selective pressure of transformation.
In contrast to the results of infection of kitten fibroblasts, the growth patterns of embryonic fibroblasts were dramatically altered by infection in vitro with myc-FeLV(FeLV) compared with growth of identical cells which were mock infected or infected with FeLV (Table 1) . Shortly after infection, the capacity of mock-infected and infected embryonic fibroblasts to proliferate when seeded at low density was examined as a parameter of transformation in vitro. Cells were seeded in four 9-cm dishes at a density of 4.5 x 104 per dish and were allowed to grow in liquid medium for 4 weeks, with weekly replenishment of the medium. After that time, it was evident by visual examination that mockinfected and FeLV-infected fibroblasts had proliferated only to a limited extent. In fact, direct cell counts demonstrated that these cells had undergone only two or three cell divisions during the experiment (data not shown). In contrast, cells infected with myc-FeLV(FeLV) had formed a nearly All plates were observed for 3 weeks for colony formation. d Leukocytes were tested for the ability to grow independently of exogenous IL-2 by being seeded at 2 x 10" cells in 5 ml of cRPMI in duplicate and counting the total number of cells on alternate days for 2 weeks. Fibroblasts were tested for the ability to grow in cRPMI with reduced serum by being plated at a density of 10" cells per ml in duplicate in medium containing 0.5% serum. Cells were observed for the ability to proliferate in this medium through at least two passages. Northern blot analysis, molecular size markers were denatured, as were RNA samples before electrophoresis. confluent monolayer. The myc-FeLV-infected cells which had grown from low-density seeding were expanded and compared in further analyses with mock-infected and FeLVinfected embryonic fibroblasts.
The proliferative potential of the embryonic fibroblasts infected with myc-FeLV(FeLV) was greatly expanded, if not infinite, since they have been maintained to date for more than 1 year as actively dividing cells in monolayer culture (Table 1) . They were morphologically distinguishable from mock-infected or FeLV-infected controls, appearing typically as blunted or broadly scalloped bipolar cells (Fig. 3A to  C) . Multinucleate cells appeared frequently in the culture (Fig. 3D) . The cells were loosely adherent, as is apparent by the presence of numerous highly refractile, rounded cells in the culture (Fig. 3C ). Because they were loosely adherent, the monolayer failed to reach a confluent density.
The capacity of mock-infected and infected embryonic fibroblasts to proliferate in medium containing reduced serum was examined as a measure of their release from the requirement for exogenously supplied growth factors. Mockinfected cells failed to grow when plated at a density of 106 cells per ml in medium with the serum concentration reduced from 10 to 0.5%, as did cells infected with either FeLV or myc-FeLV(FeLV) ( Table 1) . Embryonic fibroblasts infected with myc-FeLV(FeLV) declined rapidly in this medium and failed to survive one passage. They were capable of continued proliferation in the presence of 1.0% serum, however, and demonstrated typical morphology in this medium.
Embryonic fibroblasts appear to have been only partially transformed by infection with myc-FeLV(FeLV), as determined by several parameters. Although the cells were only loosely adherent to the substrate, proliferation remained anchorage dependent. The cells which were released into the medium from the adherent monolayer failed to proliferate as nonadherent cells (data not shown). Further, the cells did not form colonies when plated in semisolid medium (Table  1) . These cells did not form tumors when inoculated subcutaneously into athymic mice (Table 1) .
Integrated myc-FeLV provirus is readily detectable and is expressed in partially transformed embryonic fibroblasts. It is essential in these studies to document the presence and expression of myc-FeLV in transformed cells to whose establishment its activity is attributed. Southern blot analysis of DNA from partially transformed embryonic fibroblasts was performed and compared with that of mock-infected or FeLV-infected cells (Fig. 4A and B ). Hybridization to a probe representing the U3 region of the FeLV long-terminal repeat (LTR) (31) ( Fig. 4A) . The presence of discrete host-virus junction fragments in the DNA of embryonic fibroblasts (Fig. 4A , lane c) indicated that a clonal subpopulation predominates in this line. Identical analysis with a probe representing avian v-myc (50) clearly demonstrated the integrated myc-FeLV provirus in the DNA of partially transformed embryonic fibroblasts (Fig. 4B) .
Northern blot analysis of the viral RNA species extracted from virions in the culture supernatant of partially transformed embryonic fibroblasts demonstrated that the mycFeLV genome was both expressed and encapsidated (Fig.  4C) . Use in this analysis of the U3 region of the LTR (31) as probe demonstrated the presence of two species of RNA, the smaller of which was of the size predicted for the myc-FeLV genome (Fig. 4C, lane b) . Hybridization to a probe representing feline c-myc (31) confirmed the identity of this species as myc-FeLV (Fig. 4C, lane a) . Densitometric scanning of the data shown in Fig. 4C, lane Since the inoculum contained no more than 16% myc-FeLV, the infected feline fibroblasts can be expected to contain myc-FeLV proviral DNA which represents no more than 16% of the total integrated proviral DNA. That viral RNA isolated from the supernatant of these cells contains 14% myc-FeLV by mass indicates that myc-FeLV is efficiently expressed and encapsidated in feline embryonic fibroblasts.
We initially investigated the transforming potential of myc-FeLV in leukocytes derived from peripheral blood, spleen, and thymus whose proliferation in vitro was influenced by the addition of ConA and IL-2 to the culture medium, i.e., T lymphocytes. The choice of these cells was based on (i) the observation that myc-FeLV was isolated originally from a thymic lymphosarcoma (31), (ii) our preliminary evidence of a causative association between infection in vivo with myc-FeLV(FeLV) and the relatively rapid appearance of thymic lymphosarcoma (L. S. Levy, R. Fish, and G. Baskin, unpublished observations), and (iii) the observation that FeLV induces lymphosarcomas in vivo which are primarily of T-lymphoid origin (25) . We wished to determine initially the transforming potential of myc-FeLV in leukocytes cultured under the described conditions in vitro.
The results indicate that following infection with mycFeLV(FeLV), the growth parameters of leukocytes from peripheral blood, spleen, or thymus are not altered in a significant way from those of identical cells which were mock infected. This is an intriguing finding, since preliminary data indicate that myc-FeLV is capable of transforming T lymphocytes in vivo. In studies to (Table 1) , and (ii) in cells which were infected with myc-FeLV(FeLV) but not transformed, the myc-FeLV component was apparently lost from the population (Fig. 2) . In contrast, the immortalized embryonic fibroblast line contains and expresses integrated myc-FeLV proviral DNA (Fig. 4) .
The feline v-myc gene apparently responsible for the transforming activity observed in embryonic fibroblasts represents one of a small number of naturally occurring, retrovirally transduced mammalian v-myc genes, all of which have been identified in derivatives of FeLV (31, 35, 38) . It is useful to compare the biological activity of this v-myc gene with that of the avian v-myc genes and of the other mammalian v-myc genes identified to date. Like mycFeLV, the avian myc-containing viruses exhibit a transforming potential in vitro in fibroblasts which appears to be insufficient for expression of the fully transformed phenotype. Chicken fibroblasts transformed by MC29 exhibit a dramatically increased growth rate, morphological alteration, and the capacity for anchorage-independent growth in semisolid medium; however, the cells are not tumorigenic, as determined by inoculation in syngeneic chickens (22, 43) . MC29 and its relatives, CMII, OK10, and MH2, transform quail fibroblasts morphologically and render them loosely adherent, capable of anchorage-independent growth, and capable of increased, if not infinite, proliferation (16, 21, 33, 39) . The cells fail to exhibit a fully transformed phenotype, however, in that they are not tumorigenic when inoculated into athymic mice (39) . Recombinant murine retroviruses constructed to contain the v-myc gene of MC29 (12) or of OK10 (49) retain the capacity to alter the morphology of early-passage murine fibroblasts and to render them capable of unlimited proliferation and anchorage-independent growth. These activities parallel those of myc-FeLV in embryonic feline fibroblasts, except that the partially transformed feline cells fail to form colonies in semisolid medium. They are distinctly less adherent to the substrate, however, and fail to reach confluence as a monolayer for this reason.
Although little information is available about the biological activity of other naturally occurring mammalian v-myc genes, myc-FeLV appears to be distinct from other isolates examined which fail to transform fibroblastic cells in vitro (38, 45) . Assays with other isolates were performed in established fibroblastic lines, however, and it is not clear whether other myc-containing variants of FeLV are capable of transforming early-passage feline fibroblasts in vitro. In fact, myc-FeLV has no effect on established murine fibroblasts when introduced by DNA-mediated transfection (31) . myc-FeLV can be compared in coding content to CT4, another myc-containing variant of FeLV also isolated from a naturally occurring feline thymic lymphosarcoma (38, 45) . The v-myc genes of both of these viruses contain the entire coding sequence from exons 2 and 3 of c-myc and only a short remnant of exon 1 (11, 45) . The v-myc protein encoded by myc-FeLV is identical to that encoded by feline c-myc, except that v-myc sequences are expressed as a gag-myc fusion product (11, 45) . The v-myc coding sequence of CT4 differs from c-myc at three coding positions and is probably expressed independently of FeLV gag (45) . Continuing investigation of the structure and biological activity of the naturally occurring mammalian v-myc genes is important to evaluate both the function of the myc oncogene and the role it may play in virally induced oncogenesis in mammals.
